Citius Oncology Total Liabilities Growth & History (CTOR)

Citius Oncology's total liabilities was $56.1M for fiscal 2025.

View full Citius Oncology company overview

Citius Oncology annual total liabilities history

Citius Oncology annual total liabilities

Fiscal yearPeriod endedTotal liabilitiesChangeGrowth
20252025-09-30$56.1M$17.8M+46.69%
20242024-09-30$38.2M$16.0M+72.21%
2023 · Dec 312023-12-31$49.9M−$17.9M−26.45%
2023 · Sep 302023-09-30$22.2M$15.8M+245.63%
20222022-12-31$67.8M$67.7M+49590.45%
20222022-09-30$6.4M
20212021-12-31$136,535

Citius Oncology total liabilities trends

Between the periods ended 2021-12-31 and 2025-09-30, Citius Oncology's total liabilities increased from $136,535 to $56.1M, a change of $55.9M. The latest reported quarter, Q3 2026, shows $71.7M.

About the metric

What total liabilities mean

Total liabilities are all obligations reported on a company’s balance sheet, including debt, accounts payable, accrued expenses, deferred revenue, lease liabilities, and other current and long-term obligations.

Calculation and source

SEC-reported and calculated total liabilities

TickerStat uses total liabilities reported in company SEC filings when available. Otherwise, it calculates total liabilities as aligned total assets minus total equity for the same balance-sheet date. Total liabilities should not be confused with interest-bearing debt. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Citius Oncology source filings ↗

Community posts

It’s quiet here.

No posts about CTOR yet. Start the conversation.

Write the first post